Accepted Manuscript Functionalized fluorescent carbon nanoparticles for sensitively targeted of folate-receptor-positive cancer cells
Yuan Jiao, Haiyun Sun, Yanchun Jia, Yang Liu, Yifang Gao, Ming Xian, Shaomin Shuang, Chuan Dong PII: DOI: Reference:
S0026-265X(18)31629-1 https://doi.org/10.1016/j.microc.2019.01.003 MICROC 3574
To appear in:
Microchemical Journal
Received date: Revised date: Accepted date:
16 November 2018 31 December 2018 1 January 2019
Please cite this article as: Yuan Jiao, Haiyun Sun, Yanchun Jia, Yang Liu, Yifang Gao, Ming Xian, Shaomin Shuang, Chuan Dong , Functionalized fluorescent carbon nanoparticles for sensitively targeted of folate-receptor-positive cancer cells. Microc (2018), https://doi.org/10.1016/j.microc.2019.01.003
This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
ACCEPTED MANUSCRIPT Functionalized fluorescent carbon nanoparticles for sensitively targeted of folate-receptor-positive cancer cells Yuan Jiao, a Haiyun Sun, a Yanchun Jia, a Yang Liu, a Yifang Gao, a Ming Xian, a,b Shaomin Shuang, a Chuan Dong, a* a
Institute of Environmental Science, and School of Chemistry and Chemical
Department of Chemistry, Washington State University, Pullman, WA, 99164, USA.
RI
b
PT
Engineering, Shanxi University, Taiyuan 030006, China
SC
*: Corresponding author: Chuan Dong
NU
Email address:
[email protected] Tel: +86-351-7018613
MA
Fax: +86-351-7018613 Abstract
PT E
D
The folic acid-functionalized fluorescent carbon dots (FA-CDs) was synthesized via the assembly of FA to the surface of CDs. A facile hydrothermal method with proline and ethylenediamine as precursors was used to fabricate CDs. The as-prepared
CE
CDs possessed active amino groups where the CDs could be further engineered for
AC
the conjugation with FA. The uptake of the as-synthesized FA-CDs by FR positive MCF-7 cells (FR++) and HepG-2 cells (FR+) via receptor-mediated endocytosis was demonstrated by confocal laser scanning microscopy, which is further verified by a comparative study with FR-negative PC-12 cells (FR-). The bright fluorescence can be observed in FR positive MCF-7 cells while negligible fluorescence was observed in PC-12 cells with low-expressed FR, demonstrating that FA-CDs could accurately identify FR-positive cancer cells from normal cells. The FA-CDs shared favorable 1
ACCEPTED MANUSCRIPT biocompatibility, excellent optical properties and ultra-low toxicity etc. Holding these superior properties, the FA-CDs was implemented as a highly effective platform for biological labeling and imaging, which may provide a innovative vision for cancer diagnosis and succeeding personalized therapy.
PT
Keywords: Carbon dots; Folic acid-functionalized; Targeted bioimaging; Cancer cells
RI
1 Introduction
SC
Cancer remains a major public health issue worldwide [1], which has become one of the leading cause of mortality with its high recurring and death rates. Early
NU
diagnosis is of great significance for precancerous lesions, prognosis, and treatment of
MA
carcinomas [2]. The effectiveness of the cancer therapy platform has always been focused on reducing and eliminating tumours without damaging healthy tissues [3].
D
Therefore, a distinct function to target cancer cells with limited effect on healthy
PT E
tissues is the key strategy for the success of cancer therapy. In solid tumors, cancerous cells are able to form a unique permissive milieu, so-called tumor microenvironment
CE
(TME), in which cancer cells overexpress certain receptors and tumor-associated
AC
surface antigens[4, 5]. Thus, the corresponding ligands or antibodies can be utilized to improve their active identification and targeting ability to tumors, which can decrease the side effects as expected [6]. Folate acid (FA) has been recognized as one of the most important ligands for specific labeling of cancer cells owing to the over-expression of folate receptors on the membrane of cancer cells [7, 8]. Compared with other targeting molecules, folate has many advantages including relatively small molecular weight [9, 10], 2
ACCEPTED MANUSCRIPT non-immunogenicity [11-14], better stability [15], higher affinity to receptors [16] and easier modification of functional groups [17, 18] etc. Recently, numerous nanomaterials have been modified with FA for cancer’s targeting imaging, diagnosis, and therapy purposes. The commonly used nanomaterials include gold nanoparticles
PT
[19-21], silica nanoparticles [22, 23], quantum dots [24, 25], silver nanoparticles
RI
[26-28] and magnetic-fluorescent nanoparticles [29] etc. However, some of these
SC
functionalized nanomaterials are expensive and with large diameters [30] or potentially toxic effects [31] etc. Thus, the development of non-cytotoxic,
NU
cost-effective and excellent luminescence nanomaterials for targeted fluorescence
MA
imaging of cancer cells are still of important concern.
As a new type of photoluminescent (PL) nanomaterials, carbon dots (CDs) have
D
been utilized advantageously in fluorescent probes, bioimaging [32] and drug delivery
PT E
[33] due to their excellent optical properties [34, 35], high fluorescent stability [36], good biocompatibility [37] and high quantum yield [38, 39] etc. Among these
CE
applications, CDs have been extensively employed as fluorescent markers for
AC
intracellular imaging. However, the construction of carbon dots for targeted imaging is rarely reported. Ma et al. presented the first report about FA-conjugated luminescence CDs for targeting and detecting cancer cells, which open a new avenues for targeted fluorescence imaging of cancer cells [30]. Consecutively, Lei et al. developed a turn-on fluorescent nanoprobe through non-covalent conjugation of folic acid to polyethyleneimine modified CDs and demonstrated their utilization in targeted imaging of cancer cells [31]. In addition, there are some other literatures reported the 3
ACCEPTED MANUSCRIPT constructed FA functionalized CDs as a high-performance platform for accurately recognizing special cancer cells [40, 41]. Significant efforts of these pioneers have had a positive impact on the development of CDs as a diagnostic platform for cancer imaging. However, the quantum yields of fluorescent CDs immobilization with folate
PT
are relatively low. Thus, the development of targeted fluorescence CDs with excellent
RI
luminescence property becomes extremely critical to extend the utilization of CDs in
SC
targeted bioimaging.
Herein, we fabricated blue fluorescent CDs through facile one-step hydrothermal
NU
approach using proline and ethylenediamine as the carbon source and nitrogen source,
MA
respectively. The prepared CDs present a high quantum yield of 17.3% and rich in active amino groups on the surface which governed covalent conjugation with FA.
D
The FA-CDs shared some exceptional properties such as favorable biocompatibility,
PT E
excellent reversibility, and non-immunogenicity. Holding these superior properties, the FA-CDs can recognize the FR-positive MCF-7 cells, which is further confirmed
CE
by a comparative study with low-expressed FR PC-12 cells. The as-prepared FA-CDs
AC
can implement as a bioimaging platform for efficient identification of FR-positive cancer cells from normal cells, which may provide a new perspective for cancer diagnosis and therapy. 2 Experimental 2.1 Preparation of fluorescent CDs The fluorescent CDs were prepared via one-step hydrothermal strategy using proline as carbon source and ethylenediamine as nitrogen source,respectively. Firstly, 4
ACCEPTED MANUSCRIPT 0.1151 g of proline was dissolved in 10 mL of distilled water, 34 μL of EDA was added continuously for the functionalization of the carbon materials. The mixture solution was transferred to a 50 mL Teflon-lined stainless autoclave and heated at 180℃ for 5 h. The mixture was automatically cooled to room temperature. The
PT
obtained pale-yellow suspensions were freeze-dried to afford a powder.
RI
2.2 Conjugation of CDs with FA
SC
The FA-CDs was synthesized based on the known procedure [30]. In brief, 0.0100 g FA was dissolved in 6 mL PBS buffer (0.01M, pH=7.4). Then, 0.0130 g EDC and
NU
0.0078 g NHS were successively added, then the solution was stirred at room
MA
temperature overnight. 1 mL of CDs (22 mg·mL-1) dispersion was added to the resulting solution and continue the reaction for 12 h. The obtained solution was
PT E
of 500–1000 Da for 48 hours.
D
dialyzed in PBS buffer (0.01M, pH=7.4) through a dialysis membrane with MWCO
3 Results and discussion
CE
3.1 Preparation and characterization of fluorescent CDs
AC
A variety of factors affecting the preparation of CDs need to be optimized. The molar ratio of the initial raw materials, the reaction time and the heating temperature were studied in detail. As shown in Fig.S.1a and Fig.S.1c, when the material molar ratio of proline to ethylenediamine is 1:2 and the reaction temperature is 180 °C, the synthesized CDs holding exceptional fluorescence properties. The influence of reaction time on the fluorescence of CDs was demonstrated in Fig.S.1b, the fluorescence intensity of CDs enhanced gradually with the increase of reaction time. 5
ACCEPTED MANUSCRIPT When the reaction time reaches 5 hours, the fluorescence intensity has no significantly increased. Meanwhile, as the reaction time increases, the carbon powder looked much darker. Prolonged continuous heating may lead to excessive carbonization and the formation of by-products. Therefore, we choose 5h as the
PT
optimum time.
RI
The morphology of the as-prepared CDs was investigated by transmission electron
SC
microscopy (TEM). As illustrated in Fig.1a and Fig.1b, the CDs are nearly spherical and well dispersed with an average diameter of 3.13±0.34 nm. The inset of HRTEM
NU
in Fig.1a depict that the lattice spacing of CDs was 0.21 nm, which is in line with the
MA
facet (100) of graphene.
The surface functional states and components of the CDs were investigated by
D
X-ray photoelectron spectroscopy (XPS) and Fourier transform infrared (FTIR). The
PT E
survey spectrum in Fig. 1c reveals three prominent peaks of C1s at 284 eV, N1s at 400 eV and O1s at 531 eV [42-44]. The typical C1s spectrum (Fig. 1d) exhibits four distinct
CE
peaks located at 283.9, 285.0, 286.9 and 288.0 eV, which correspond to C- C/C-H,
AC
C-N, C-O and C=O groups, respectively. The N1s spectrum (Fig.1e) can be deconvoluted into three components at 398.2, 400.1 and 402 eV, attributed to C-N, N-H and pyrrolic N, respectively. The O1s spectrum (Fig.S.2) exhibits two peaks at 530.0 and 531.2eV, representing -C=O and C-OH/C-O-C. The FTIR spectrum was shown in Fig.1f, the absorption bands 3440 and 2995 cm-1 represent the typical stretching vibrations of O-H/N-H and C-H, respectively. Simultaneously, the absorption band at 1626 cm-1 is attributed to the stretching vibration of C=O. Several 6
ACCEPTED MANUSCRIPT sharp peaks at 1511, 1411 and 1031 cm-1 correspond to the vibrations of N-H, C=C and C-N, respectively. The analytical results of XPS and FTIR demonstrate that there existed effective -NH2 and -COOH groups on the surface of as-synthesized CDs, which can be directly conjugated with FA without further modification.
PT
As shown in fig.2a, the CDs exhibit maximum emission peak centered at 405 nm
RI
when excitation at 320 nm. The inset of Fig.2a demonstrates that the pale-yellow CDs
SC
solution emitted intense blue luminescence under UV light at 365 nm. The excitation-wavelength-dependent PL behavior of CDs was described in Fig.2b. The
NU
PL spectra are batho-chromically red-shift with the increase of excitation wavelengths
MA
in the range of 280 to 420 nm. Meanwhile, the intensity of the emission peak first increases and then gradually decreases. It reaches a maximum at an excitation of
320
nm,
indicating
that
the
prepared
CDs
has
an
D
wavelength
PT E
excitation-wavelength-dependent PL behavior. Furthermore, using quinine sulfate as a reference (QY = 58% in 0.1M H2SO4, λex= 350 nm), the relative quantum yield (QY)
CE
of the fluorescent CDs was measured to be 17.3% at λex/λem of 350/370–680nm.
AC
3.2 Characterization of FA-CDs The CDs possessed active amino groups where the CDs could be covalently bound to FA via a covalent bond reaction. As shown in Fig.3a, the average diameter of FA-CDs is 3.38 ± 0.49 nm, which slightly larger than CDs after conjugated with folic acid. The Zeta potential of CDs and FA-CDs were -11.1 and -22.6 mV (Fig.3b), suggesting the surface of the carbon dot has been successfully covered by FA with negatively charged. According to UV–vis absorption spectra, the blue line in Fig.3c 7
ACCEPTED MANUSCRIPT existed two dominant absorbance peaks located at 261 and 307 nm, we propose that the strong absorption peak of CDs at 261nm correspond to the π-π* transition of the aromatic sp2. The absorption peak at 307 nm is attributed to the n→π* transition of the C-N bond. As shown in black line in Fig.3c, the characteristic absorption peaks of
PT
FA at 282 nm and 361 nm is emerged in the UV–vis absorption spectra of FA-CDs,
RI
demonstrating that FA has been connected to the surface of CDs successfully. This
SC
result is further confirmed by FTIR (Fig.3d), the absorption peak at 1691 cm-1 is attributed to C=O stretching of –COOH on folic acid. Meanwhile, other absorption
NU
bands at 1604 and 1480 cm-1 are attributed to the phenyl and pterin rings. All these
MA
characteristic peaks of FA are reflected in the FA-CDs, demonstrating FA has fixed on the surface of the CDs successfully.
D
3.3 Photostabilities of FA-CDs
PT E
The photostability of FA-CDs was verified by measuring the fluorescent intensity under continuous irradiation with a xenon arc lamp for 60 min (Fig.S3), the
CE
fluorescence intensity was continuously monitored and recorded at λex/λem
AC
=320/405nm. The PL intensity of FA-CDs has no obvious change in comparison with CDs, which demonstrated that the FA-CDs possess excellent photostability and can be utilized to bioimaging applications. Fig.S4 shows that the CDs and FA-CDs maintains a nearly constant fluorescence intensity in the pH region of 3 to 11. The effects of different concentration of NaCl on the PL stability of CDs and FA-CDs were described in Fig.S5. The PL intensity and spectral feature of FA-CDs do not change much at different concentrations of NaCl, 8
ACCEPTED MANUSCRIPT which is beneficial to the practical use of FA-CDs under physical salt conditions. Moreover, the influence of commonly cell substances on the fluorescence of CDs and FA-CDs was described in Fig.S6. These substances show no significant interference on the fluorescence intensity of FA-CDs, which certificate that FA-CDs can be a good
PT
candidate for the biological imaging.
RI
3.4 Targeted imaging of FA-CDs to FR-positive cancer cells
SC
The cytotoxicity of FA-CDs was determined by a standard MTT assay with FR+ HepG-2 cells. As shown in Fig.S7, the cell viability remained at approximately 87%
NU
after incubation of HepG-2 with FA-CDs at concentrations ranging from 0 to 200
MA
μg·mL-1, demonstrating low toxicity of the FA-CDs and inferring their potential use in the biological system.
D
To assess the feasibility of the prepared FA-CDs for recognition cancer cells,
PT E
FR-positive MCF-7 cells (FR++), HepG2 cells (FR+) and FR-negative PC-12 cells (FR-) were selected for comparison experiment of cell targeting imaging. As
CE
demonstrated in Fig.4, It is obvious that MCF-7 cells display bright blue fluorescence
AC
after incubation with the FA-CDs for 2h. However, there only weak fluorescence is shown in PC-12 cells with low-expressed FR. The fluorescence intensity of HepG2 cells is in an intermediate order among the three cell lines. All these results indicate that FA-CDs can discrimination of FR-positive cancer cells from normal cells via receptor-mediated endocytosis, which demonstrated that FA-CDs are a good candidate for targeted biological imaging of cancer cells. Demonstration results have been described in some representative work[45-47], which conjugated magnetic 9
ACCEPTED MANUSCRIPT nanoparticles (MNPs) with folic acid (FA) and loaded anticancer chemotherapeutics for targeted imaging and therapy of cancer. Consecutively, some developed researches have concentrated on designing targeted substance-conjugated metal quantum dots [48, 49] or chitosan micellar nanoparticles[50] for multifunctional fluorescence
PT
targeted imaging and cancer diagnosis. All these reports showed a significant
RI
instrument for developing new targeted material and further demonstrating our works
SC
reliability for constructed folic acid-functionalized fluorescent carbon dots as a highly effective platform for biological labeling and imaging.
NU
Moreover, in order to investigate that whether FA-CDs entrance into the cells is
MA
via receptor-mediated endocytosis, a competition experiment was conducted where MCF-7 cells were saturated with an excess of free FA firstly and then incubated with
D
FA-CDs under the same culture conditions. The result shows that there is no
PT E
fluorescence signal in the MCF-7 cells (Fig.S8), which may attribute to the specific binding between FA and folic acid receptor of cancer cells. Meanwhile, the result also
AC
endocytosis.
CE
proved that FA-CDs can target recognition of cancer cells via receptor-mediated
4 Conclusion
In summary, we developed an efficient approach for targeted bioimaging of cancer cells through covalent modification of FA on the surface of CDs. The prepared FA-CDs shared excellent optical properties, favorable biocompatibility, and ultra-low toxicity etc. Holding these exceptional properties, the FA-CDs can be implemented as a good candidate for a biological system. The comparative experiments of MCF-7 10
ACCEPTED MANUSCRIPT cells (FR++), HepG2 cells (FR+) and (FR-) PC-12 cells demonstrated that FA-CDs can accurately identify FR-positive cancer
cells
from
normal
cells
via
receptor-mediated endocytosis. The FA-CDs can serve as a promising nanomaterial to construct a high-performance platform for biological imaging of cancer cells, which
PT
have great potential significance for cancer diagnostic studies.
RI
Conflicts of interest
SC
There are no conflicts to declare. Acknowledgments
NU
This work was supported by the National Natural Science Foundation of China
MA
(No.21705101, 21475080 and 21575084) and the Hundred Talent Programme of
PT E
Notes and references
D
Shanxi Province.
[1] M. Zhang, W. Wang, Y. Cui, N. Zhou, J. Shen, Magnetofluorescent Carbon Quantum Dot Decorated Multiwalled Carbon Nanotubes for Dual-Modal Targeted Imaging in Chemo-Photothermal Synergistic Therapy, ACS Biomaterials Science & Engineering, 4 (2017) 151-162.
CE
[2] E.S. Permyakova, I.V. Sukhorukova, L.Y. Antipina, A.S. Konopatsky, A.M. Kovalskii, A.T. Matveev, O.I. Lebedev, D.V. Golberg, A.M. Manakhov, D.V. Shtansky, Synthesis and Characterization of Folate Conjugated Boron Nitride Nanocarriers for Targeted Drug Delivery, The Journal of Physical Chemistry C,
AC
121 (2017) 28096-28105.
[3] A. Pawar, S. Singh, S. Rajalakshmi, K. Shaikh, C. Bothiraja, Development of fisetin-loaded folate functionalized pluronic micelles for breast cancer targeting, Artif Cells Nanomed Biotechnol, (2018) 1-15.
[4] J. Barar, Y. Omidi, Dysregulated pH in Tumor Microenvironment Checkmates Cancer Therapy, Bioimpacts, 3 (2013) 149-162. [5] O. Y, B. J, Targeting tumor microenvironment: crossing tumor interstitial fluid by multifunctional nanomedicines, Bioimpacts, 4 (2014) 55-67. [6] Y. Fong, C.-H. Chen, J.-P. Chen, Intratumoral Delivery of Doxorubicin on Folate-Conjugated Graphene Oxide by In-Situ Forming Thermo-Sensitive Hydrogel for Breast Cancer Therapy, Nanomaterials, 7 (2017) 388. [7] Y.-P. Wu, J. Yang, H.-Y. Gao, Y. Shen, L. Jiang, C. Zhou, Y.-F. Li, R.-R. He, M. Liu, Folate-Conjugated 11
ACCEPTED MANUSCRIPT Halloysite Nanotubes, an Efficient Drug Carrier, Deliver Doxorubicin for Targeted Therapy of Breast Cancer, ACS Applied Nano Materials, 1 (2018) 595-608. [8] P. Thapa, M. Li, R. Karki, M. Bio, P. Rajaputra, G. Nkepang, S. Woo, Y. You, Folate-PEG Conjugates of a Far-Red Light-Activatable Paclitaxel Prodrug to Improve Selectivity toward Folate Receptor-Positive Cancer Cells, ACS Omega, 2 (2017) 6349-6360. [9] R. Li, X. Wang, Z. Li, H. Zhu, J. Liu, Folic acid-functionalized graphene quantum dots with tunable fluorescence emission for cancer cell imaging and optical detection of Hg2+, New Journal of Chemistry, 42 (2018) 4352-4360. [10] A.R. Chowdhuri, S. Tripathy, C. Haldar, S. Chandra, B. Das, S. Roy, S.K. Sahu, Theoretical and enhance antibacterial activity, RSC Advances, 5 (2015) 21515-21524.
PT
experimental study of folic acid conjugated silver nanoparticles through electrostatic interaction for
RI
[11] H. Liu, Z. Li, Y. Sun, X. Geng, Y. Hu, H. Meng, J. Ge, L. Qu, Synthesis of Luminescent Carbon Dots with Ultrahigh Quantum Yield and Inherent Folate Receptor-Positive Cancer Cell Targetability,
SC
Scientific Reports, 8 (2018).
[12] W. Li, Q. Liu, P. Zhang, L. Liu, Zwitterionic nanogels crosslinked by fluorescent carbon dots for targeted drug delivery and simultaneous bioimaging, Acta Biomaterialia, 40 (2016) 254-262.
NU
[13] D. Lei, W. Yang, Y. Gong, J. Jing, H. Nie, B. Yu, X. Zhang, Non-covalent decoration of carbon dots with folic acid via a polymer-assisted strategy for fast and targeted cancer cell fluorescence imaging, Sensors and Actuators B: Chemical, 230 (2016) 714-720.
MA
[14] S. Bhunia, A. Maity, S. Nandi, D. Stepensky, R. Jelinek, Imaging cancer cells expressing the folate receptor with carbon dots produced from folic acid, Chembiochem, 17 (2016) 614-619. [15] D. Li, Y. Ma, Y. Zhang, Z. Lin, Fluorescence biosensor for folate receptors in cancer cells based on terminal protection and hyperbranched rolling circle amplification, Analytical Methods, 8 (2016)
D
6231-6235.
[16] J. Wang, J. Liu, PEI–folic acid modified carbon nanodots for cancer cell-targeted delivery and
PT E
two-photon excitation imaging, RSC Advances, 6 (2016) 19662-19668. [17] J. Tian, L. Ding, Q. Wang, Y. Hu, L. Jia, J.S. Yu, H. Ju, Folate receptor-targeted and cathepsin B-activatable nanoprobe for in situ therapeutic monitoring of photosensitive cell death, Anal Chem, 87 (2015) 3841-3848.
CE
[18] Q. Liu, S. Xu, C. Niu, M. Li, D. He, Z. Lu, L. Ma, N. Na, F. Huang, H. Jiang, J. Ouyang, Distinguish cancer cells based on targeting turn-on fluorescence imaging by folate functionalized green emitting carbon dots, Biosens Bioelectron, 64 (2015) 119-125.
AC
[19] J. Keyvan Rad, A.R. Mahdavian, S. Khoei, S. Shirvalilou, Enhanced Photogeneration of Reactive Oxygen Species and Targeted Photothermal Therapy of C6 Glioma Brain Cancer Cells by Folate-Conjugated Gold–Photoactive Polymer Nanoparticles, ACS Applied Materials & Interfaces, 10 (2018) 19483-19493.
[20] S.S.D. Kumar, A. Mahesh, M.G. Antoniraj, H.S. Rathore, N.N. Houreld, R. Kandasamy, Cellular imaging and folate receptor targeting delivery of gum kondagogu capped gold nanoparticles in cancer cells, International Journal of Biological Macromolecules, 109 (2017) 220. [21] S. Malekmohammadi, H. Hadadzadeh, H. Farrokhpour, Z. Amirghofran, Immobilization of gold nanoparticles on folate-conjugated dendritic mesoporous silica-coated reduced graphene oxide nanosheets: a new nanoplatform for curcumin pH-controlled and targeted delivery, Soft Matter, 14 (2018) 2400-2410. [22] J. Soleymani, M. Hasanzadeh, M.H. Somi, N. Shadjou, A. Jouyban, Probing the Specific Binding of 12
ACCEPTED MANUSCRIPT Folic Acid to Folate Receptor using Amino-functionalized Mesoporous Silica Nanoparticles for Differentiation of MCF 7 Tumoral Cells from MCF 10A, Biosensors & Bioelectronics, (2018). [23] W. Cheng, J. Nie, L. Xu, C. Liang, Y. Peng, G. Liu, T. Wang, L. Mei, L. Huang, X. Zeng, pH-Sensitive Delivery Vehicle Based on Folic Acid-Conjugated Polydopamine-Modified Mesoporous Silica Nanoparticles for Targeted Cancer Therapy, ACS Appl Mater Interfaces, 9 (2017) 18462-18473. [24] J. Zhang, X. Zhao, M. Xian, C. Dong, S. Shuang, Folic acid-conjugated green luminescent carbon dots as a nanoprobe for identifying folate receptor-positive cancer cells, Talanta, 183 (2018) 39. [25] X. Miao, D. Qu, D. Yang, B. Nie, Y. Zhao, H. Fan, Z. Sun, Synthesis of Carbon Dots with Multiple Color Emission by Controlled Graphitization and Surface Functionalization, Adv Mater, 30 (2018).
PT
[26] M.S. Khan, A. Talib, S. Pandey, M.L. Bhaisare, G. Gedda, H.F. Wu, Folic Acid navigated Silver Selenide nanoparticles for photo-thermal ablation of cancer cells, Colloids Surf B Biointerfaces, 159
RI
(2017) 564-570.
[27] S. Bocafarcau, M. Potara, T. Simon, A. Juhem, P. Baldeck, S. Astilean, Folic acid-conjugated,
SC
SERS-labeled silver nanotriangles for multimodal detection and targeted photothermal treatment on human ovarian cancer cells, Mol Pharm, 11 (2014) 391-399.
[28] Y. Wang, B.B. Newell, J. Irudayaraj, Folic acid protected silver nanocarriers for targeted drug
NU
delivery, Journal of Biomedical Nanotechnology, 8 (2012) 751-759.
[29] M. Shen, W. Jia, C. Lin, G. Fan, Y. Jin, X. Chen, G. Chen, Facile synthesis of folate-conjugated magnetic/fluorescent bifunctional microspheres, Nanoscale Research Letters, 9 (2014) 558.
MA
[30] Y. Song, W. Shi, W. Chen, X. Li, H. Ma, Fluorescent carbon nanodots conjugated with folic acid for distinguishing folate-receptor-positive cancer cells from normal cells, Journal of Materials Chemistry, 22 (2012) 12568-12573.
[31] D. Lei, W. Yang, Y. Gong, J. Jing, H. Nie, B. Yu, X. Zhang, Non-covalent decoration of carbon dots
D
with folic acid via a polymer-assisted strategy for fast and targeted cancer cell fluorescence imaging, Sensors & Actuators B Chemical, 230 (2016) 714-720.
PT E
[32] J. Qian, F. Quan, F. Zhao, C. Wu, Z. Wang, L. Zhou, Aconitic acid derived carbon dots: Conjugated interaction for the detection of folic acid and fluorescence targeted imaging of folate receptor overexpressed cancer cells, Sensors and Actuators B: Chemical, (2018). [33] J. Jiao, C. Liu, X. Li, J. Liu, D. Di, Y. Zhang, Q. Zhao, S. Wang, Fluorescent carbon dot modified
CE
mesoporous silica nanocarriers for redox-responsive controlled drug delivery and bioimaging, Journal of Colloid & Interface Science, 483 (2016) 343-352. [34] S. Lu, L. Sui, J. Liu, S. Zhu, A. Chen, M. Jin, B. Yang, Near ‐Infrared Photoluminescent
AC
Polymer–Carbon Nanodots with Two‐Photon Fluorescence, Advanced Materials, 29 (2017) 1603443.
[35] S.K. Bhunia, S. Nandi, R. Shikler, R. Jelinek, Tuneable light-emitting carbon-dot/polymer flexible films prepared through one-pot synthesis, Nanoscale, 8 (2016) 3400-3406. [36] X. Gong, W. Lu, Y. Liu, Z. Li, S. Shuang, C. Dong, M.M.F. Choi, Low temperature synthesis of phosphorous and nitrogen co-doped yellow fluorescent carbon dots for sensors and bioimaging, Journal of Materials Chemistry B, 3 (2015) 6813-6819. [37] W. Lu, X. Gong, N. Ming, L. Yang, S. Shuang, C. Dong, Comparative study for N and S doped carbon dots: Synthesis, characterization and applications for Fe 3+ probe and cellular imaging, Analytica Chimica Acta, 898 (2015) 116. [38] S. Sun, L. Zhang, K. Jiang, A. Wu, H. Lin, Towards High-efficient Red Emissive Carbon Dots: Facile Preparation, Unique Properties, and Applications as Multifunctional Theranostic Agents, Chemistry of 13
ACCEPTED MANUSCRIPT Materials, 28 (2016). [39] L. Li, C. Lu, S. Li, S. Liu, L. Wang, W. Cai, W. Xu, X. Yang, Y. Liu, R. Zhang, A high-yield and versatile method for the synthesis of carbon dots for bioimaging applications, Journal of Materials Chemistry B, 5 (2017). [40] Q. Liu, S. Xu, C. Niu, M. Li, D. He, Z. Lu, L. Ma, N. Na, F. Huang, H. Jiang, Distinguish cancer cells based on targeting turn-on fluorescence imaging by folate functionalized green emitting carbon dots, Biosensors & Bioelectronics, 64 (2015) 119-125. [41] D. Nicholas, C. Fowley, A.P. Mchale, S. Kamila, J. Sheng, J. Atchison, J.F. Callan, A folic acid labelled carbon quantum dot-protoporphryin IX conjugate for use in folate receptor targeted two-photon SPIE BiOS, 2015, pp. 933813-933813-933815.
PT
excited photodynamic therapy,
[42] S. Sarkar, D. Gandla, Y. Venkatesh, P.R. Bangal, S. Ghosh, Y. Yang, S. Misra, Graphene quantum dots
RI
from graphite by liquid exfoliation showing excitation-independent emission, fluorescence upconversion and delayed fluorescence, Phys Chem Chem Phys, 18 (2016) 21278-21287.
SC
[43] D.W. Zheng, B. Li, C.X. Li, J.X. Fan, Q. Lei, C. Li, Z. Xu, X.Z. Zhang, Carbon-Dot-Decorated Carbon Nitride Nanoparticles for Enhanced Photodynamic Therapy against Hypoxic Tumor via Water Splitting, ACS Nano, 10 (2016) 8715-8722.
NU
[44] L. Li, C. Lu, S. Li, S. Liu, L. Wang, W. Cai, W. Xu, X. Yang, Y. Liu, R. Zhang, A high-yield and versatile method for the synthesis of carbon dots for bioimaging applications, Journal of Materials Chemistry B, 5 (2017) 1935-1942.
MA
[45] M.M. Heidari, D. Asgari, J. Barar, H. Valizadeh, V. Kafil, G. Coukos, Y. Omidi, Specific targeting of cancer cells by multifunctional mitoxantrone-conjugated magnetic nanoparticles, Journal of Drug Targeting, 21 (2013) 328-340.
[46] M.M. Heidari, D. Asgari, J. Barar, H. Valizadeh, V. Kafil, A. Abadpour, E. Moumivand, J.S. Mojarrad,
D
M.R. Rashidi, G. Coukos, Tamoxifen loaded folic acid armed PEGylated magnetic nanoparticles for targeted imaging and therapy of cancer, Colloids & Surfaces B Biointerfaces, 106 (2013) 117-125.
PT E
[47] J. Barar, V. Kafil, M.H. Majd, A. Barzegari, S. Khani, M. Johari-Ahar, D. Asgari, G. Cokous, Y. Omidi, Multifunctional mitoxantrone-conjugated magnetic nanosystem for targeted therapy of folate receptor-overexpressing malignant cells, Journal of Nanobiotechnology, 13 (2015) 26. [48]
M.
Johari-Ahar,
J.
Barar,
A.M.
Alizadeh,
S.
Davaran,
Y.
Omidi,
M.R.
Rashidi,
CE
Methotrexate-conjugated quantum dots: synthesis, characterisation and cytotoxicity in drug resistant cancer cells, Journal of Drug Targeting, 24 (2015) 120. [49] Z. Ranjbarnavazi, M. Eskandani, M. Johariahar, A. Nemati, H. Akbari, S. Davaran, Y. Omidi,
AC
Doxorubicin-conjugated D-glucosamine- and folate- bi-functionalised InP/ZnS quantum dots for cancer cells imaging and therapy, Journal of Drug Targeting, 26 (2017) 1. [50] M. Fathi, P.S. Zangabad, A. Aghanejad, J. Barar, H. Erfan-Niya, Y. Omidi, Folate-conjugated thermosensitive O -maleoyl modified chitosan micellar nanoparticles for targeted delivery of erlotinib, Carbohydrate Polymers, 172 (2017) 130.
14
ACCEPTED MANUSCRIPT Figure captions Scheme.1 Illustration of the synthetic of the FA-CDs and the FA-CDs based fluorescence bioimaging platform for the targeted imaging of FR+ cancer cells. Fig.1 (a) TEM image and HRTEM image (top inset) of as-synthesised CDs; (b)
PT
Particle size distribution of CDs; (c) XPS survey scan of CDs; (d) C1s XPS and (e) N1s
RI
XPS and of CDs; (f) FTIR spectrum of CDs.
SC
Fig.2 (a) Fluorescence spectra of CDs; Inset: Photographs of CDs under visible (left) and UV light (right) at 365 nm; (b) Excitation–emission matrix for CDs at different
NU
excitation wavelengths.
MA
Fig.3 (a) TEM image and particle size distribution (top inset) of FA-CDs; (b) Zeta potential distributions of the CDs (top) and FA-CDs (down); (c) UV-vis absorption
PT E
CDs and (c) FA.
D
spectra of (a) FA-CDs, (b) CDs and (c) FA; (d) FTIR spectrum of (a) FA-CDs, (b)
Fig.4 Confocal images of the MCF-7 cell, HepG 2 cell, and PC-12 cell after incubated
AC
CE
with FA-CDs.
15
ACCEPTED MANUSCRIPT
AC
CE
PT E
D
MA
NU
SC
RI
PT
Scheme.1
16
ACCEPTED MANUSCRIPT
AC
CE
PT E
D
MA
NU
SC
RI
PT
Fig. 1
17
ACCEPTED MANUSCRIPT
AC
CE
PT E
D
MA
NU
SC
RI
PT
Fig. 2
18
ACCEPTED MANUSCRIPT
AC
CE
PT E
D
MA
NU
SC
RI
PT
Fig. 3
19
ACCEPTED MANUSCRIPT
AC
CE
PT E
D
MA
NU
SC
RI
PT
Fig.4
20
ACCEPTED MANUSCRIPT Highlights 1. The fluorescent CDs were facilely prepared by hydrothermal method and present a high quantum yield of 17.3%, which is advantageous in bioimaging applications.
PT
2. The fluorescent CDs possessed active amino groups where the CDs could be
RI
engineered for the conjugation with FA directly without further modification.
SC
3. Outstanding performance of the FA-CDs with favorable biocompatibility, high photostability and ultra-low toxicity, which can implemented as a bioimaging
NU
platform for efficient identification of FR-positive cancer cells from normal cells.
MA
4. The FA-CDs can implemented as a highly effective platform for biological labeling and imaging, which may provide a new tool for cancer diagnosis and
AC
CE
PT E
D
succeeding personalized therapy.
21